1. Adjarov, D G, Elder, G H: Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria. In: Morris, C R, Cabral, J R P (Eds) Hexachlorobenzene: Proceedings of an International Symposium, IARC, Lyon, France, 24–28 June 1985, Oxford: University Press 1986. pp 467–469
2. Alleman, M A, Koster, J F, Wilson, J H P et al: The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria. Biochem. Pharmacol. 34, 161–166 (1985)
3. Andrews, J E, Courtney, K D: Inter- and intraindividual variation of HCB deposition in fetuses. Toxicol, appl. Pharmacol. 37, 128–133 (1985)
4. Auras, D: Die Harder’sche Drüse mit besonderer Berücksichtigung ihres Porphyrin-Haushalts. Dissertation, Düsseldorf 1974
5. Baart de la Faille, H: Erythropoetische Protoporphyrie. In: Körting, G W (Ed) Dermatologie in Praxis und Klinik III. Stuttgart: Thieme 1979. p 38.69–38.82